Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.

NCT Number	NCT04285476
Lead Sponsor	Institut du Cancer de Montpellier - Val d'Aurelle
Conditions	Thyroid Cancer
Enrollment	71 participants
Start Date	2021-06-17
Primary Completion	2026-07 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-04